Adrenocortical carcimona: Surgery and mitotane for treatment and steroid profiles for follow-up

World Journal of Surgery

Volumn 22, Issue 6, 1998, Pages 605-612

  Khorram Manesh, A ^a   Ahlman, H ^a   Jansson, S ^a   Wangberg B ^a   Nilsson, O ^a   Jakobsson, C E ^a   Eliasson, B ^a   Lindstedt, S ^a   Tisell, L E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HYDROCORTISONE; INTERFERON; MITOTANE; PREGNANEDIOL; PREGNANETRIOL; STREPTOZOCIN; 17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; DOSE RESPONSE; FEMALE; HUMAN; LIVER METASTASIS; MALE; NAUSEA; RASH; SECOND LOOK SURGERY; STEROID URINE LEVEL; TREATMENT OUTCOME; VISUAL IMPAIRMENT; ADRENAL CORTEX TUMOR; ARTICLE; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; URINE;

17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOTANE;

EID: 0032094302     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900442     Document Type: Conference Paper

References (34)

1. Gröndal, S., Cedermark, B., Eriksson, B., Grimelius, L., Harach, R., Kristoffersson, A., Rastad, J., Udèn, P., Åkerström, G.: Adrenocortical carcinoma: a retrospective study of a rare tumor with a poor prognosis. Eur. J. Surg. Oncol. 16:500, 1990
2. Henley, D.J., van Heerden, J.A., Grant, C.S., Carney, J.A., Carpenter, P.C.: Adrenal cortical carcinoma: a continuing challenge. Surgery 94:926, 1983
3. Van Slooten, H., Schaberg, A., Smeenk, D., Moolenar, A.J.: Morphological characteristics of benign and malignant adrenocortical tumours. Cancer 55:766, 1985
4. Cohn, K., Gottesman, L., Brennan, M.: Adrenocortical carcinoma. Surgery 100:1170, 1986
5. Luton, J.P., Cerdas, S., Billand, L., Thomas, G., Guihaume, B., Bertagna, X., Landat, M.H., Louvel, A., Chapuis, Y., Blandeau, P., Bonnin, A., Bricaire, H.: Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N. Engl. J. Med. 322:1195, 1990
6. Venkatesh, S., Hickey, R.C., Sellin, R.V., Fernandez, J.F., Samaan, N.A.: Adrenal cortical carcinoma. Cancer 64:765, 1989
7. Icard, P., Chapuis, Y., Andreassian, B., Bernard, A., Proye, C.: Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 112:972, 1992
8. Pommier, R.F., Brennan, M.F.: An eleven year experience with adrenocortical carcinoma. Surgery 112:963, 1992
9. Haak, H.R., Hermans, J., van de Valde, C.J.H., Lentjes, E.G.W.M., Goslings, B.M., Fleuren, G.J., Krans, H.M.J.: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br. J. Cancer 69:947, 1994
10. Kasperlik-Zaluska, A.A., Migdalska, B.M., Zgliczynski, S., Makowska, A.M.: Adrenocortical carcinoma: a clinical study and treatment result of 52 patients. Cancer 75:2587, 1995
11. Hough, A.J., Hollifield, J.W., Page, D.L., Hartmann, W.H.: Prognostic factors in adrenal cortical tumors. Am. J. Clin. Pathol. 72:390, 1979
12. Weiss, L.M.: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8:163, 1984
13. Medeiros, L.J., Weiss, L.M.: New developments in the pathologic diagnosis of adrenal cortical neoplasms. Am. J. Clin. Pathol. 97:73, 1991
14. Lee, J.E., Berger, D.H., El-Naggar, A.K., Hickey, R.C., Vassilopoulou-Sellin, R., Gagel, R.F., Burgess, A.M., Evans, D.B.: Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 118:1090, 1995
15. Lipsett, M.B., Hertz, R., Ross, G.T.: Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am. J. Med. 35:374, 1963
16. Lubitz, J.A., Freeman, L., Okun, R.: Mitotane use in inoperable adrenal cortical carcinoma. J.A.M.A. 223:1109, 1973
17. Schteingart, D.E., Motazedi, A., Noonan, R.A., Thompson, N.W.: Treatment of adrenal carcinoma. Arch. Surg. 117:1142, 1982
18. Kintzer, P.P., Peterson, M.E.: Mitotane treatment of 32 dogs with Cortisol secreting adrenocortical neoplasms. J. Am. Vet. Med. Assoc. 205:54, 1994
19. Axelson, M., Sahlberg, B.L., Sjövall, J.: Analysis of profiles of conjugated steroids in urine by ion-exchange separation and gas chromatography-mass spectrometry. Chromatogr. Biomed. Appl. 224:355, 1981
20. Minowada, S., Kinosluta, K., Hara, M., Isurugi, K., Vehikawa, T., Niijima, T.: Measurement of urinary steroid profile in patients with adrenal tumor as screening method for carcinoma. Endocrinol. Jpn. 32:29, 1985
21. Schmidt, N.A., Borburgh, H.J., Penders, T.J., Weykamp, C.W.: Steroid profiling: an update. Clin. Chem. 31:637, 1985
22. Homoki, J., Hol, R., Teller, W.M.: Harnsteroid Profile bei Cushing Syndrom und Tumoren der Nebennierenrinde. Klin. Wochenschr. 65:719, 1987
23. Weykamp, C.W., Penders, T.J., Schmidt, N.A., Borbourgh, A.J., van de Calseyde, J.F., Wolthers, B.J.: Steroid profile for urine: reference value. Clin. Chem. 35:2281, 1989
24. Degenhardt, H.J., Drop, S.L.S., Hoogerbrugge, J., van Seters, A.P., de Vries, H.R.: In vitro studies of enzymatic activities in human adrenal tumors. Horm. Res. 16:96, 1982
25. Doerr, H.G., Sippell, W.G., Drop, S.L.S., Bidlingmaier, F., Knorr, D.: Evidence of 11-β-hydroxylase deficiency in childhood adrenocortical tumor. Cancer 60:1625, 1987
26. Moolenaar, AJ., Niewint, J.W.M., Oei, I.T.: Estimation of o,p′-DDD in plasma by gas liquid-chromatography. Clin. Chem. Acta 76:213, 1977
27. Van Slooten, H., Moolenaar, A.J., Van Seters, A.P., Smeenk, D.: The treatment of adrenocortical carcinoma with o,p′-DDD: prognostic implications of serum level monitoring. Eur. J. Cancer Clin. Oncol. 20:47, 1984
28. Didolkar, M.S., Bescher, A., Elias, E.G., Moor, R.H.: Natural history of adrenal cortical carcinoma. Cancer 47:2153, 1981
29. Sullivan, M., Bojkan, M., Hodges, C.V.: Adrenal cortical carcinoma. J. Urol. 120:660, 1978
30. Huffman, D.L., Mattox, V.R.: Treatment of adrenocortical carcinoma with o,p′'-DDD. Med. Clin. North Am. 56:999, 1972
31. Dogliotti, L., Berruti, A., Pia, A., Paccotti, P., Ali, A., Angeli, A.: Cytotoxic chemotherapy for adrenocortical carcinoma. Minerva Endocrinol. 20:105, 1995
32. Weiss, L.M., Medeiros, L.J., Vickery, A.L.: Pathologic features of prognostic significance in adrenocortical carcinoma. Am. J. Surg. Pathol. 13:202, 1989
33. MacFarlane, D.A.: Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann. R. Coll. Surg. Engl. 25:155, 1958
34. Nader, S., Hickey, R.C., Sellin, R.V., Samaan, N.A.: Adrenal cortical carcinoma: a study of 77 cases. Cancer 52:707, 1983